These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
410 related items for PubMed ID: 15229902
1. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA. Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902 [Abstract] [Full Text] [Related]
5. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC). Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L. Cancer Detect Prev; 1981 Jul; 4(1-4):307-12. PubMed ID: 6299561 [Abstract] [Full Text] [Related]
6. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma]. Mendoza J, Rojas A, de la Rosa M, Amador JM, Expósito J, Esquivias J. Med Clin (Barc); 1991 Nov 09; 97(16):609-11. PubMed ID: 1662737 [Abstract] [Full Text] [Related]
7. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma. Luo YL, Ou GP, Chi PD, Liang YN, Liu YH, Huang MY. Ai Zheng; 2009 Jan 09; 28(1):76-8. PubMed ID: 19448423 [Abstract] [Full Text] [Related]
8. [A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients]. Ji MF, Guo YQ, Liang JS, Zheng SA, Cheng WM, Yu BH, Ou XT, Wang DK. Zhonghua Zhong Liu Za Zhi; 2003 May 09; 25(3):243-5. PubMed ID: 12839685 [Abstract] [Full Text] [Related]
10. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM. J Clin Microbiol; 2006 Apr 09; 44(4):1459-67. PubMed ID: 16597877 [Abstract] [Full Text] [Related]
11. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma. Zhang C, Zong Y, Huang B, Sun Y, Ye Y, Feng K, Li J, Zhang F. Zhonghua Zhong Liu Za Zhi; 2002 Jul 09; 24(4):356-9. PubMed ID: 12408763 [Abstract] [Full Text] [Related]
13. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y. Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466 [Abstract] [Full Text] [Related]
18. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC. Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842 [Abstract] [Full Text] [Related]
20. Subtype distribution and long-term titer fluctuation patterns of serum anti-Epstein-Barr virus antibodies in a non-nasopharyngeal carcinoma population from an endemic area in South China: a cohort study. Du JL, Chen SH, Huang QH, Xie SH, Ye YF, Gao R, Guo J, Yang MJ, Liu Q, Hong MH, Cao SM. Chin J Cancer; 2016 Aug 15; 35(1):78. PubMed ID: 27527073 [Abstract] [Full Text] [Related] Page: [Next] [New Search]